Bergert Patricia, Henkelmann Ralf, Hepp Pierre, Theopold Jan
Division of Arthroscopic and special Joint Surgery / Sports Injuries, Department of Orthopedics, Trauma and Plastic Surgery, University of Leipzig, Leipzig, Germany.
PLoS One. 2025 Jan 3;20(1):e0316440. doi: 10.1371/journal.pone.0316440. eCollection 2025.
The number of reverse shoulder arthroplasty (RSA) procedures performed worldwide has increased over the last 10 years, with a corresponding increase in revision shoulder arthroplasty (SRSA). SRSA is often used for post-traumatic revision surgery in cases of infections and failure of anatomical prostheses. Data on outcomes with specific detail for each indication for the prosthetic solution as a secondary treatment are scarce, and inhomogeneous.
The questionnaires were sent by mail to 65 patients who underwent SRSA between January 2014 and November 2023. Based on the indications for SRSA, patients were categorized into post-traumatic shoulder arthritis, humeral head necrosis, failed proximal humerus fractures, failed proximal humerus osteosynthesis, prostheses loosening, and infection groups.
Of the 65 patients included in the study, 39 completed the questionnaire, and the mean follow-up duration was 44 months (range, 12-104 months). The Constant score ranged from 28 points for all 6 groups (range, 38-66). The post-infection group showed the highest results, with 66 points (range, 24-90) on the Constant score; followed by 26 points (range, 49-6) points on the DASH score; and 0.90 (range, 0.763-1) on the EQ-5D-5L. Failed proximal humerus fractures presented the lowest scores: 38 points (range, 22-63) on the Constant score; 51 points (range, 73-30) points on the DASH score; and 0.61 (range, -0.496-1) on the EQ-5D-5L.
No previous study has investigated the influence of indications on the clinical outcome of SRSA so circumstantial. In this study, the highest outcome scores were observed in the post-infection group, whereas the lowest scores were observed in the failed humerus fracture group. Our results underline the influence of the indication on the clinical outcome of SRSA.
在过去10年中,全球范围内进行的反肩关节置换术(RSA)数量有所增加,翻修肩关节置换术(SRSA)也相应增加。SRSA常用于创伤后翻修手术,治疗感染和解剖型假体失败的病例。关于作为二级治疗的假体解决方案各适应症具体细节的结果数据稀缺且不统一。
通过邮件向2014年1月至2023年11月期间接受SRSA的65例患者发送问卷。根据SRSA的适应症,将患者分为创伤后肩关节炎、肱骨头坏死、肱骨近端骨折失败、肱骨近端骨合成失败、假体松动和感染组。
纳入研究的65例患者中,39例完成了问卷,平均随访时间为44个月(范围12 - 104个月)。Constant评分在所有6组中范围为28分(范围38 - 66)。感染后组结果最佳,Constant评分为66分(范围24 - 90);其次,DASH评分为26分(范围49 - 6);EQ - 5D - 5L评分为0.90(范围0.763 - 1)。肱骨近端骨折失败组得分最低:Constant评分为38分(范围22 - 63);DASH评分为51分(范围73 - 30);EQ - 5D - 5L评分为0.61(范围 - 0.496 - 1)。
此前尚无研究如此详细地调查适应症对SRSA临床结果的影响。在本研究中,感染后组的结果评分最高,而肱骨骨折失败组的评分最低。我们的结果强调了适应症对SRSA临床结果的影响。